Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Covington
Citi
Medtronic
Daiichi Sankyo
Moodys

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,595,760

« Back to Dashboard

Summary for Patent: 5,595,760
Title: Sustained release of peptides from pharmaceutical compositions
Abstract:The invention features a method of administering a peptide to a patient and delivering the peptide continuously over an extended period of time of at least three days by obtaining a solid pharmaceutical composition including a soluble, gelable salt of the peptide and up to 30 percent, by weight, of a pharmaceutically acceptable, soluble, monomeric carrier, and parenterally administering the solid composition to the patient in one injection, wherein the solid composition automatically forms a gel after interaction with the patient's bodily fluids and releases the peptide continuously within the patient over an extended period of at least three days.
Inventor(s): Cherif-Cheikh; Roland (Issy-les-Moulineaux, FR)
Assignee: Delab (Paris, FR)
Application Number:08/400,610
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,595,760
Patent Claim Types:
see list of patent claims
Use; Delivery; Composition; Dosage form;

Drugs Protected by US Patent 5,595,760

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074-001 Aug 30, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING LANREOTIDE ACETATE ➤ Sign Up
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074-002 Aug 30, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING LANREOTIDE ACETATE ➤ Sign Up
Ipsen Pharma SOMATULINE DEPOT lanreotide acetate SOLUTION;SUBCUTANEOUS 022074-003 Aug 30, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up Y METHOD OF ADMINISTERING LANREOTIDE ACETATE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Daiichi Sankyo
Julphar
McKesson
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.